James V. Freeman, MD, MPH, MS, is a cardiologist who specializes in treating cardiac arrhythmias.
He is nationally known for his expertise performing specialized arrhythmia procedures including ablation of complex arrhythmias (supraventricular tachycardias, atrial fibrillation and flutter, and ventricular tachycardia), left atrial appendage occlusion, and placing implantable cardiac devices such as pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices.
Dr. Freeman is director of Cardiac Electrophysiology for Yale New Haven Health and director of the Yale Atrial Fibrillation Program. He has a master of public health degree with a concentration in biostatistics and epidemiology from Johns Hopkins and a master of science degree in health services research from Stanford.
Dr. Freeman has published extensively on topics of comparative effectiveness, cost-effectiveness, and clinical outcomes with cardiac arrhythmias. He has served as the lead researcher on studies funded by the National Institutes of Health, the American College of Cardiology, and the American Heart Association to study the safety and effectiveness of therapies for the prevention and treatment of atrial fibrillation, ventricular fibrillation/tachycardia, sudden cardiac death, stroke, and heart failure.
